Hippocrates Ventures

What is Hippocrates Ventures?

Hippocrates Ventures is a social impact venture capital firm with a focused investment thesis on digital therapeutics. Situated in New York, New York, they emphasize on investment opportunities that not only have the potential for financial returns but also aim to create significant positive social impact.

A key area within their portfolio is healthcare technology, specifically investing in companies that are developing innovative solutions to healthcare challenges through the use of digital platforms. Their investments include evidence-based therapeutic applications that leverage technology to deliver improved patient outcomes. For instance, Hippocrates Ventures has invested in Smileyscope, a company utilizing virtual reality neuromodulation to enhance patient experiences in medical procedures like burns dressings and medical imaging.

Another portfolio company, Avive AED, is focused on increasing the survival rate for sudden cardiac arrest by providing reliable life-saving tools and building engaging technology. Additionally, they have backed Fruit Street, which delivers the CDC's diabetes prevention program through telehealth and live group video conferencing facilitated by registered dietitians.

Through such investments, Hippocrates Ventures demonstrates a commitment to improving healthcare access, efficiency, and effectiveness, while generating social value and fostering innovation in the healthcare sector. They are a forward-thinking partner for startups that are at the intersection of technology and wellness, striving to make a tangible difference in people’s lives through their investment activities.

What they say:

We are a venture capital fund supported by physicians.

What we look for: We invest in social impact, digital health, and therapeutics.